Marks Electrical Group PLC 37.8% potential upside indicated by Canaccord Genuity

Marks Electrical Group PLC with ticker (LON:MRK) now has a potential upside of 37.8% according to Canaccord Genuity.



Canaccord Genuity set a target price of 123 GBX for the company, which when compared to the Marks Electrical Group PLC share price of 89 GBX at opening today (27/10/2023) indicates a potential upside of 37.8%. Trading has ranged between 61 (52 week low) and 110 (52 week high) with an average of 165,508 shares exchanging hands daily. The market capitalisation at the time of writing is £95,503,590.

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, including biological therapies, vaccines and animal health products. The Company’s Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription for the treatment of human disorders. It sells human health pharmaceutical products to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers. The Company’s Animal Health segment develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products as well as health management solutions for the prevention, treatment and control of disease in all livestock and companion animal species. The Company’s product MK-7240 is used for the treatment of immune-mediated diseases including ulcerative colitis, and Crohn’s disease.